Endocrine Abstracts

Neuroendocrine tumors of the GI-tract have attained increased attention during the last decades. The incidence of these rare neoplasms is about 2.5-4.0 per 100.000 per year.The most significant developments within the management of neuroendocrine GI-tumors have been in the areas of histopathology, tumor markers, localisation procedures and treatment. A new WHO-classification system has emerged which not only classify the tumor as neuroendocrine, but also...

Kjell E Öberg, Department of Endocrine Oncology University Hospital, Uppsala, Sweden AbstractDr Kjell Öberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University. He is the head of the Endocrine Oncology Clinic and a specialist in endocrinology and internal medicine. He founded the Clinic of Endocrine Oncology at Uppsala University Hospital and has more than 20 years experience in t...